24.3 C
Jalandhar
Friday, October 22, 2021

ਵਾਹਿਗੁਰੂ

spot_img
yes punjab punjabi redirection

Mera Ghar

Loan Waiver

Kisan Victims

Water Bills

Electricity Bills

Invest Punjab

Group D

Parali

PSSSB Chemical

Markfed Sept to Nov

Innocent

Indian-American researcher identifies 4 possible treatments for Coronavirus

- Advertisement -

New York, May 5, 2020-

An Indian-American scientist-led team from the University of Missouri has found that four antiviral drugs, including remdesivir, a drug originally developed to treat Ebola, are effective in inhibiting the replication of the coronavirus causing COVID-19.

Kamlendra Singh, an associate professor in the College of Veterinary Medicine, and his team used computer-aided drug design to examine the effectiveness of remdesivir, 5-fluorouracil, ribavirin and favipiravir in treating COVID-19.

According to the study, published in the journal Pathogens, Singh found that all four drugs were effective in inhibiting, or blocking, the coronavirus’ RNA proteins from making genomic copies of the virus.

“As researchers, we have an obligation to search for possible treatments given that so many people are dying from this virus,” Singh said.

These antiviral drugs, if they turn out to be effective, all have some limitations.

“But in the midst of a global pandemic, they are worth taking a deeper look at because based on our research, we have reason to believe that all of these drugs could potentially be effective in treating COVID-19,” he added.

The coronavirus (SARS-CoV-2) that causes COVID-19, like all viruses, can mutate and develop resistance to antiviral drugs.

Therefore, further testing in a laboratory setting and in patients is needed to better evaluate how the proposed treatments interact with the virus’ RNA polymerase.

“Our goal is to help doctors by providing options for possible treatments of COVID-19, and to ultimately contribute in improving the health outcomes of patients suffering from the infectious disease,” Singh said.

Singh’s research is an example of translational medicine, a key component of the University of Missouri System’s NextGen Precision Health Initiative.

The NextGen initiative aims to improve large-scale interdisciplinary collaboration in pursuit of life-changing precision health advancements and research.

Meanwhile, the US is planning to begin treating some of the most seriously ill COVID-19 patients with the antiviral medication Remdesivir, the maker of the drug has announced, as tensions continued across the country over the economic reopening of states.

Last week, the US Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for the experimental anti-viral drug remdesivir to treat COVID-19.

As of Tuesday, confirmed cases in the country has reached 1,180,634 with 68,934 deaths, according to the tally maintained by the Johns Hopkins University.  (Agency)


For YesPunjab updates on TELEGRAM, download TELEGRAM and CLICK HERE TO SUBSCRIBE


- Advertisement -

Yes Punjab - TOP STORIES

Punjab News

Sikh News

Transfers, Postings, Promotions

- Advertisement -spot_img

Stay Connected

20,369FansLike
112,653FollowersFollow

ENTERTAINMENT

National

GLOBAL

OPINION

Security Force in Kashmir

Kashmir: A battle that has been laid off for far too long- by Amjad Ayub Mirza

On October 22, 1947 Pakistan attacked the State of Jammu and Kashmir. It was the beginning of a conflict that would leave thousands dead...
Indian Population

In the light of the population explosion debate – by Nirendra Dev

Mizoram has made news -- not necessarily for the wrong reasons but certainly for quite unexpected reasons. North-Eastern India generally makes news due to...
Terrorists Shadow

Tackling the resurgence of jihad in Kashmir – by Amjad Ayub Mirza

With three encounters taking place in less than 24 hours between October 10 and 11, terrorist insurgency has effectively resurged in the Kashmir Valley....

SPORTS

Health & Fitness

Breast Cancer

50% rise in breast cancer among middle-aged women in India: Report

New Delhi, Oct 22, 2021- Since the last three years, there has been a 50 per cent rise in middle-aged women (aged 35-50 years) reporting cases of breast cancer in India, said doctors at a private hospital here on Friday. The estimates are based on OPD records by doctors, the Indraprastha Apollo Hospitals said in a statement. "Based on our records...

Gadgets & Tech